WS #4083

The dominant signal in this 10-minute window is the Trump administration's aggressive trade policy announcements, specifically new tariffs on patented pharmaceutical imports and adjustments to metals tariffs, which could significantly impact healthcare and industrial sectors. The pharmaceutical tariffs, detailed in a White House fact sheet and corroborated by multiple breaking Reuters-sourced posts, impose a 100% tariff on patented drug imports unless manufacturers sign U.S. pricing deals or move production stateside, with reduced rates for some trade partners and exemptions for compliance—this directly pressures large pharma companies and may affect drug pricing, potentially moving tickers like PFE, MRK, and JNJ. Concurrently, steel, aluminum, and copper tariff adjustments aim to simplify compliance but maintain high duties, which could raise costs for manufacturers and impact industrials and materials stocks. Additionally, geopolitical tensions persist with Iran-related developments, including a report of IRGC taking de facto control amid power struggles and Polymarket trades on ceasefire timelines, adding uncertainty that may pressure energy markets and broad indices. In corporate news, UBS analyst actions continue with price target cuts for Aptiv and Conagra Brands, indicating bearish sentiment in autos and consumer staples, while Tesla's delivery miss is noted as pressuring TSLA stock. Other items, such as the firing of Pam Bondi (already highlighted in previous context) and routine filings, are noise without new market-moving details.